Laurus Bio Profile
Key Indicators
- Authorised Capital ₹ 38.44 Cr
as on 04-07-2024
- Paid Up Capital ₹ 2.59 M
as on 04-07-2024
- Company Age 19 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 120.00 Cr
as on 04-07-2024
- Satisfied Charges ₹ 34.83 Cr
as on 04-07-2024
- Revenue 28.20%
(FY 2023)
- Profit -29.50%
(FY 2023)
- Ebitda 11.51%
(FY 2023)
- Net Worth 40.93%
(FY 2023)
- Total Assets 54.88%
(FY 2023)
About Laurus Bio
The Corporate was formerly known as Richcore Lifesciences Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 38.44 Cr and a paid-up capital of Rs 2.59 M.
The company currently has active open charges totaling ₹120.00 Cr. The company has closed loans amounting to ₹34.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Laurus Bio Private Limited India is Rajesh Krishnamurthy as CEO. Rajaram, Aruna Bhinge, Uma Vasireddi, and Five other members serve as directors at the Company.
- CIN/LLPIN
U02423KA2005PTC036770
- Company No.
036770
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2005
- Date of AGM
30 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Laurus Bio?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Krishnamurthy | CEO | 01-Oct-2022 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aruna Bhinge  | Director | 16-Aug-2022 | Current |
| Rajaram | Director | 30-Jan-2021 | Current |
| Uma Vasireddi | Director | 20-Jan-2021 | Current |
| Krishnakalyan Dhandapani | Whole-Time Director | 23-May-2014 | Current |
| Venkata Vantaram | Director | 20-Jan-2021 | Current |
| Chava Satyanarayana | Director | 20-Jan-2021 | Current |
Financial Performance and Corporate Structure Insights of Laurus Bio.
Laurus Bio Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.2% increase. The company also saw a substantial fall in profitability, with a 29.5% decrease in profit. The company's net worth Soared by an impressive increase of 40.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Laurus Bio?
In 2023, Laurus Bio had a promoter holding of 18.26% and a public holding of 81.74%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pharmaceuticals Export Promotion Council Of IndiaActive 20 years 8 monthsChava Satyanarayana is a mutual person
Laurus Labs LimitedActive 19 years 3 monthsAruna Bhinge, Venkata Vantaram and 1 more are mutual person
Immunoadoptive Cell Therapy Private LimitedActive 6 years 2 monthsChava Satyanarayana is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 25 May 2021 | ₹95.00 Cr | Open |
Citi Bank N.A. Creation Date: 25 May 2021 | ₹25.00 Cr | Open |
Others Creation Date: 13 Nov 2020 | ₹8.00 Cr | Satisfied |
How Many Employees Work at Laurus Bio?
Laurus Bio has a workforce of 347 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Laurus Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Laurus Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
